dr. ir. B.H.M. (Bas) van der Velden
Researcher/Postdoc
- Image Sciences Institute
Contact
Biography
Bas van der Velden (1986) is a postdoctoral researcher at the University Medical Center Utrecht. He received his PhD in Medical Imaging at Utrecht University and his MSc degree in Medical Engineering at the Eindhoven University of Technology. He has experience at research labs in the USA (UC Berkeley and Memorial Sloan Kettering Cancer Center).
Bas’s research focuses on breast cancer prognosis and personalized treatment using medical image analysis and machine learning.
Research Output (20)
Radiogenomic Analysis of Breast Cancer by Linking MRI Phenotypes with Tumor Gene Expression
Bismeijer Tycho, van der Velden Bas H M, Canisius Sander, Lips Esther H, Loo Claudette E, Viergever Max A, Wesseling Jelle, Gilhuijs Kenneth G A, Wessels Lodewyk F A 26 mei 2020, In: Radiology. 296 , p. 277-287 11 p.
Interpretable deep learning regression for breast density estimation on MRI
Van Der Velden Bas H.M., Ragusi Max A.A., Janse Markus H.A., Loo Claudette E., Gilhuijs Kenneth G.A. 1 jan 2020,
Synchronous Breast Cancer:Phenotypic Similarities on MRI
Wang Hui, van der Velden Bas H M, Chan Hui Shan M, Loo Claudette E, Viergever Max A, Gilhuijs Kenneth G A 19 dec 2019, In: Journal of Magnetic Resonance Imaging. 51 , p. 1858-1867 10 p.
Are contralateral parenchymal enhancement on dynamic contrast-enhanced MRI and genomic ER-pathway activity in ER-positive/HER2-negative breast cancer related?
van der Velden Bas H M, Bismeijer Tycho, Canisius Sander, Loo Claudette E, Lips Esther H, Wesseling Jelle, Viergever Max A, Wessels Lodewyk F A, Gilhuijs Kenneth G A 16 okt 2019, In: European Journal of Radiology. 121
Response monitoring of breast cancer on DCE-MRI using convolutional neural network-generated seed points and constrained volume growing
van der Velden BHM, de Vos Bob D., Loo Claudette E., Kuijf HJ, Isgum I, Gilhuijs KG 2019, 10950
Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients
van der Velden BHM, Sutton Elizabeth, Carbonaro Luca, Pijnappel Ruud, Morris Elizabeth, Gilhuijs Kenneth nov 2018, In: European Radiology. 28 , p. 4705-4716 12 p.
Perfusion in the contralateral breast on preoperative MRI may complement ER-pathway activity from the index tumor to stratify outcome of endocrine therapy for early-stage invasive breast cancer
Van der Velden B., Bismeijer T., Canisius S., Loo C., Lips E., Wesseling J., Viergever M., Wessels L., Gilhuijs K. apr 2018, In: European Journal of Cancer. 92 , p. S49-S50
Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle
Merckel LG, Verburg Erik, van der Velden Bas H M, Loo Claudette E., van den Bosch Maurice A A J, Gilhuijs Kenneth G A 2018, In: The Breast Journal. 24 , p. 501-508
Analysis of healthy breast tissue on MRI for prognosis of breast cancer
van der Velden B.H.M. 21 dec 2017, 143 p.
Complementary value of contralateral parenchymal enhancement on DCE-MRI to prognostic models and molecular assays in high-risk ER+HER2- breast cancer
van der Velden Bas H M, Elias Sjoerd G, Bismeijer Tycho, Loo Claudette E., Viergever Max A, Wessels Lodewyk F A, Gilhuijs Kenneth G A 2017, In: Clinical Cancer Research. 23 , p. 6505-6515 11 p.